Pseudomonas cepacia resistance to antibacterials. 1979

R M Richards, and J M Richards

Reproducible growth rates of Pseudomonas cepacia were obtained. P. cepacia had a markedly different resistance pattern to single and combined antibacterials from that characteristic of Pseudomonas aeruginosa. Benzalkonium and chlorhexidine were more active against log phase P. cepacia than against log phase P. aeruginosa, but polymyxin B sulfate was inactive against log phase P. cepacia at all concentrations tested (smaller than or equal to 16 units/ml). Antagonism of antibacterial activity between edetate disodium-benzalkonium and edetate disodium-chlorhexidine combinations was marked with 16-hr P. cepacia and with 16-hr Staphylococcus aureus. Phenylethanol-benzalkonium and phenylethanolchlorhexidine combinations had no more than additive activity against log phase P. cepacia. These results have relevance to hospital disinfection and preservation of pharmaceutical solutions.

UI MeSH Term Description Entries
D011549 Pseudomonas A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants. Chryseomonas,Pseudomona,Flavimonas
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.

Related Publications

R M Richards, and J M Richards
December 1979, Journal of bacteriology,
R M Richards, and J M Richards
July 1982, Journal of pharmaceutical sciences,
R M Richards, and J M Richards
February 1994, The Journal of applied bacteriology,
R M Richards, and J M Richards
January 1954, Bollettino dell'Istituto sieroterapico milanese,
R M Richards, and J M Richards
April 2010, Nature reviews. Drug discovery,
R M Richards, and J M Richards
April 1994, Archives of disease in childhood,
R M Richards, and J M Richards
May 1986, Infection control : IC,
R M Richards, and J M Richards
August 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R M Richards, and J M Richards
April 1989, Antimicrobial agents and chemotherapy,
R M Richards, and J M Richards
February 1989, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!